Significant ototoxicity seen with
Selected Abstract
Significant ototoxicity seen with once-daily gentamicin dosing in stem cell transplant recipients
From The University of Texas MD Anderson Cancer Center, Houston-The use of single daily doses (SDD) of gentamicin (in combination with other antibiotics) is gaining acceptance in febrile neutropenic patients who receive high-dose chemotherapy with bone marrow or peripheral blood stem cell ...
August 1, 1998; Formulary
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Significant ototoxicity seen with once-daily gentamicin dosing in stem cell transplant recipients
2.
Steps for developing and implementing a DVT treatment protocol in the outpatient setting
|